266 related articles for article (PubMed ID: 26456120)
21. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
22. Mining the fecal proteome: from biomarkers to personalised medicine.
Jin P; Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2017 May; 14(5):445-459. PubMed ID: 28361558
[TBL] [Abstract][Full Text] [Related]
23. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
[TBL] [Abstract][Full Text] [Related]
24. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research.
Tyanova S; Cox J
Methods Mol Biol; 2018; 1711():133-148. PubMed ID: 29344888
[TBL] [Abstract][Full Text] [Related]
25. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
Stepczynska A; Schanstra JP; Mischak H
Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
[TBL] [Abstract][Full Text] [Related]
26. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
27. Proteomics of ovarian cancer: functional insights and clinical applications.
Elzek MA; Rodland KD
Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
[TBL] [Abstract][Full Text] [Related]
28. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometry-based proteomic analysis of formalin-fixed paraffin-embedded extrahepatic cholangiocarcinoma.
Maeda S; Morikawa T; Takadate T; Suzuki T; Minowa T; Hanagata N; Onogawa T; Motoi F; Nishimura T; Unno M
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):683-91. PubMed ID: 25917007
[TBL] [Abstract][Full Text] [Related]
30. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
31. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
33. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
34. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
Mermelekas G; Zoidakis J
Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
[TBL] [Abstract][Full Text] [Related]
35. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
Pham TV; Piersma SR; Oudgenoeg G; Jimenez CR
Expert Rev Mol Diagn; 2012 May; 12(4):343-59. PubMed ID: 22616700
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
37. Targeted Proteomics for Studying Pathogenic Bacteria.
Saleh S; Staes A; Deborggraeve S; Gevaert K
Proteomics; 2019 Aug; 19(16):e1800435. PubMed ID: 31241236
[TBL] [Abstract][Full Text] [Related]
38. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
39. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
40. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
